QCM
PTCT icon

Quantinno Capital Management’s PTC Therapeutics PTCT Stock Holding History

Quantinno Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Buy
22,988
+16,382
+248% +$1.18M ﹤0.01% 2030
2026
Q1 		$450K Buy
6,606
+372
+6% +$26.3K ﹤0.01% 2790
2025
Q4 		$474K Buy
6,234
+808
+15% +$58.7K ﹤0.01% 2487
2025
Q3 		$333K Sell
5,426
-1,309
-19% -$68.2K ﹤0.01% 2375
2025
Q2 		$329K Sell
6,735
-1,851
-22% -$87.9K ﹤0.01% 1953
2025
Q1 		$438K Sell
8,586
-1,070
-11% -$53.4K ﹤0.01% 1434
2024
Q4 		$436K Buy
+9,656
New +$413K ﹤0.01% 1266

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Quantinno Capital Management's PTCT Position: Q2 2026 in Review

Quantinno Capital Management increased its PTC Therapeutics (PTCT) stake by 248% in Q2 2026, buying an estimated $1.18M and bringing the position to 22,988 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

Quantinno Capital Management first reported a position in PTCT in Q4 2024 and has held it in 7 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Quantinno Capital Management held 22,988 shares of PTC Therapeutics worth $1.88M as of Q2 2026.
  • Quantinno Capital Management bought 16,382 PTC Therapeutics shares in Q2 2026, an estimated $1.18M.
  • PTC Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2030 holding.
  • Quantinno Capital Management first reported a position in PTC Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.